Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pain

Case Study: 66-Year-Old Man with Visual Loss, Headache, Hematuria, Chronic Sinusitis

Eli Miloslavsky, MD  |  May 8, 2012

A 66-year-old man presented to the hospital with left-sided visual loss, headache, hematuria, and symptoms of a chronic sinusitis.

Filed under:ConditionsVasculitis Tagged with:ANCAANCA-Associated VasculitisDiagnosisdrugGlucocorticoidsgranulomatosis with polyangiitishematuriaimagingrheumatologistrituximabTreatmentVasculitisvisual loss

Drug Updates: Citalopram hydrobromide, Statins, and More

Michele B. Kaufman, PharmD, BCGP  |  May 8, 2012

Information on new approvals and medication safety

Filed under:Drug Updates Tagged with:ApprovalsBiologicsdrugJAK inhibitorsjanus kinasePipelineRheumatoid arthritisSafetyStatin

Lupus Survey Finds Gaps in Communication

Alexandra Schultz  |  May 2, 2012

More than 90% of systemic lupus erythematosus (SLE) patients experience a communication gap with their family and with their care team, according to a recent survey conducted by GfK Roper North America. The survey found that many SLE patients downplay their symptoms to friends, family, and even their doctors.

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:communicationLupusPatientsSLE

Basics of Biologic Joint Reconstruction

Andreas Gomoll, MD  |  April 6, 2012

For young patients especially, this can delay knee replacement and provide better outcomes.

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:bonecartilage repairimagingkneeOsteoarthritispatient careradiographrheumatologist

New Osteoarthritis Recommendations and Classification Criteria for Sjögren’s Syndrome and Polymyalgia Rheumatica

Kathy Holliman  |  April 6, 2012

The ACR has published three documents intended to provide clarity and consensus on management of osteoarthritis, classification criteria for Sjögren’s syndrome, and classification criteria for polymyalgia rheumatica. The documents, which represent the most current clinical evidence, research, and expert panel input and review, can help inform clinical practice and provide clearer target populations for future research.

Filed under:Clinical Criteria/GuidelinesConditionsOsteoarthritis and Bone DisordersOther Rheumatic ConditionsSjögren’s Disease Tagged with:AC&RAmerican College of Rheumatology (ACR)Classification CriteriaGuidelinesOsteoarthritisPolymyalgia RheumaticarheumatologistSjogren's

Reflections on Living with Lupus, and on Treating It

Simon M. Helfgott, MD  |  April 6, 2012

There are some people whose purpose in life is to entertain. Some of us are fortunate to have them as our patients.

Filed under:ConditionsOpinionRheuminationsSpeak Out RheumSystemic Lupus Erythematosus Tagged with:cardiac tamponadedrugHelfgottHYDROXYCHLOROQUINELupusPathogenesispatient careprednisonerheumatologistSystemic lupus erythematosustherapeuticsTreatment

Five Ways to Get Involved in the American College of Rheumatology (ACR) Simple Tasks Campaign

Staff  |  April 6, 2012

Last September, the ACR launched its first public relations campaign, called Simple Tasks. Here are five ways you can become a part of this important campaign.

Filed under:From the CollegeLegislation & AdvocacyProfessional Topics Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)LegislationrheumatologistSimple Tasks

Pediatric Researcher Turns American College of Rheumatology (ACR) Award into a Learning Experience

Staff  |  April 6, 2012

Yukiko Kimura, MD, has been interested in medical education for a long time, so when the ACR Research and Education Foundation (REF) awarded her the ACR REF Clinician Scholar Educator Award in 2008, she knew what she wanted to do.

Filed under:AwardsCareer DevelopmentEducation & TrainingFrom the CollegeProfessional TopicsProfilesResearch Rheum Tagged with:AC&RAmerican College of Rheumatology (ACR)AwardsClinical researchEducationPediatricsProfileREF NewsrheumatologistRheumatology Research Foundation

Treatment Patterns and Trends for Spondylarthropathies

Vanessa Caceres  |  April 6, 2012

Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.

Filed under:Axial SpondyloarthritisConditionsDrug UpdatesPsoriatic Arthritis Tagged with:ACR/ARHP Annual MeetingAnkylosing Spondylitisanti-inflammatorydrugGlucocorticoidsMethotrexatepatient carePsoriatic ArthritisReactive arthritisRheumatoid arthritis

Rheumatoid Arthritis Drugs May Cut Cardiovascular Risk

Kathleen Louden  |  April 6, 2012

Other studies at the ACR/ARHP Annual Scientific Meeting in November examined arthritis treatment, scleroderma screening.

Filed under:Biologics/DMARDsConditionsDrug UpdatesOsteoarthritis and Bone DisordersRheumatoid ArthritisSystemic Sclerosis Tagged with:ACR/ARHP Annual MeetingcardiovasculardrugJuvenile idiopathic arthritisMethotrexateOsteoarthritisPainpatient careRheumatoid arthritisrheumatologistSclerodermaTofacitinibTreatment

  • « Previous Page
  • 1
  • …
  • 204
  • 205
  • 206
  • 207
  • 208
  • …
  • 243
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences